U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040137) titled 'Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration' on June 25.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase III study to evaluate the efficacy and safety of KPS-0373 given once daily after breakfast in 142 patients with spinocerebellar degeneration . This study consists of the 4-week screening period, 24-week treatment period, and 4-week follow-up period.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Spinocerebellar Degeneration
Intervention:
DRUG: KPS-0373
Oral administration
DRUG: Placebo
Oral administration
Rec...